* SK bioscience's board approval follows the Financial Services Commission's May 28 announcement ...
* SK bioscience collaborates with Colombia's government-led US$260 million vaccine localization i...
* Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventiv...
* SK–IDT–Vaxxas consortium establishes strategic entry point for high-density microarray patch (H...
* Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Fami...
* CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccine ...
* Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune ...
* Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses * Phase 1/...
* Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completio...
* Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to ...
* Company aims for technology advancement and platform expansion with Korea's first influenza vac...
* No patent infringement found in exports of individual conjugate bulk substances and research-us...
* Company aims to develop a bird flu vaccine with rapid mass production and variant responsivenes...
* SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials inAustralia and N...
* SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials inAustralia i...
* This approval paves the way for exports to the world's fourth most populous country. * SK bio...
* This approval paves the way for exports to the world's fourth most populous country. * SK bio...
* SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation...
* SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a centur...
* Company exported 440,000 doses to Thailand, marking its entry into the Southeast Asian market a...
